Anti-Depressants and Anxiety
Antihistamines
Blocking Agents
Paid and Inflammation
  Home > Drug Companies > Sigma Tau Pharmaceuticals, Inc.



 

Pharmaceutical Courses

 
Pharmacy Technician
Allied College
Arnold, MO
Pharmacy Technician
Allied College
Saint Ann, MO
Pharmacy Technician
Cambridge College
Portland, OR
Pharmacy Technician
Cambridge College
Seattle, WA
Pharmacy Technician
High Tech Institute
Irving, TX
Pharmacy Technician
High Tech Institute
Atlanta, GA
Pharmacy Technician
High Tech Institute
Memphis, TN
Pharmacy Technician
High Tech Institute
Minneapolis, MN
Pharmacy Technician
High Tech Institute
Orlando, FL
Pharmacy Technician
High Tech Institute
Sacramento, CA
Pharmacy Technician
The Bryman School
Phoenix, AZ
 

Sigma-Tau Pharmaceuticals, Inc.

Advertising Information for rxboomer
Sigma Tau Pharmaceuticals is a rare corporation dedicated to creating novel therapies for the unmet needs of patients with rare diseases. Truly unique in its field, Sigma Tau places its considerable scientific resources behind the discovery of compounds that benefit the few. Simply because it's the right thing to do.

By maintaining an environment based on integrity, honesty, and placing the patient first, Sigma Tau is able to consider what may be a small commercial success nothing less than a human triumph. To them, there is no greater accomplishment than helping the little girl who is suffering from corneal cystinosis or the man with Hodgkin's lymphoma.

There are diseases so rare that they only affect a few thousand, or even a few hundred, people. At Sigma Tau Pharmaceuticals their mission is to help ensure these people are not left untreated. They are dedicated to providing new therapies and new hope for patients with rare diseases. Sigma Tau Pharmaceuticals a wholly owned U.S. subsidiary of Sigma Tau is particularly proud of its research in the area of rare diseases. A rare disease is defined as any disease or condition which affects less than 200,000 persons in the United States. Sigma Tau’s core belief and dedication is that the study of rare diseases should be an integral part of their research activity.

The Company has always believed that research in molecular biology would bring about the subdivision of diseases into smaller subgroups, and that the experience accumulated in the field of rare diseases would be essential to the development of a new generation of pharmaceuticals. This endeavor is underscored by the fact that in 1984 Sigma-Tau became the fourth company in the world to obtain an Orphan Drug Designation in the United States.

Sigma-Tau Pharmaceuticals is dedicated to developing and providing innovative therapies to patients who suffer from rare diseases. Their areas of concentration include the development of prescription pharmaceuticals for rare diseases.

Sigma-Tau Consumer Products, a division of Sigma-Tau Pharmaceuticals, is committed to producing high quality nonprescription medicines and dietary supplements that help to support the normal functions of your body.

Back to Drug Companies

 
 
Antibiotics
Bisphosphonates
Oral Contraceptives and Menopause
Advertise Now
Infinit-i